00849nas a2200313   4500000000100000008004100001260001300042653001600055653001200071653003300083653003000116653001100146653002300157653001200180653001600192653002500208653001400233653002300247653001300270653003000283100001600313700001300329245009400342856005000436300001000486490000700496050001800503022001400521       2012                            d  c2012 Sep10aClofazimine10aDapsone10aDrug Administration Schedule10aDrug Therapy, Combination10aHumans10aLeprostatic Agents10aleprosy10aMinocycline10aMycobacterium leprae10aOfloxacin10aPatient Compliance10aRifampin10aWorld Health Organization1 aLockwood DN1 aCunha MG00aDeveloping new MDT regimens for MB patients; time to test ROM 12 month regimens globally.  uhttps://leprosyreview.org/article/83/3/00-241  a241-40 v83  aLOCKWOOD 2012  a0305-7518